Back
HMDN
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Heramed Limited
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
N/A
Annual Growth
5 years average annual capital growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
3
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Heramed Limited - Ordinary Fully Paid Deferred
๐ Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in HMDN
0
๐ Total Capital Earnings
N/A
๐ Average investment frequency
N/A
๐ต Average investment amount
N/A
โฐ Last time a customer invested in HMDN
N/A
HMDN investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in HMDN also invest in...
HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-12-12. The firm is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The firm offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Companyโs proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.
๐ Performance (5Yr p.a)
-14.67%
๐ Share price
$0.04 AUD
๐ฉบ HEALTH CARE
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
18.13%
๐ Share price
$154.83 AUD
๐ HIGH PRICE GROWTH
๐ค TECHNOLOGY
๐ GLOBAL
โณ๏ธ DIVERSIFIED
Magellan Financial Group Ltd. engages in the provision of funds management services. The company is headquartered in Sydney, New South Wales and currently employs 111 full-time employees. The company went IPO on 2004-07-01. The Companyโs segments include Funds Management, Fund Investments and Associate Investments. The Funds Management segment provides investment fund management services to high net worth and retail investors in Australia and New Zealand, and to institutional investors globally. Its Funds Management activities include providing investment research and administrative services to certain clients; providing investment management and sub-advisory services under client mandates, and acting as responsible entity/trustee (RE) and/or investment manager (IM) for the funds (collectively the Magellan Funds). The Fund Investments segment comprises its direct investment in certain Magellan Funds and a select portfolio of listed Australian and international equities. The Associate Investments segment comprises a portfolio of selective investments in businesses in which it has a strategic interest.
๐ Performance (5Yr p.a)
-16.79%
๐ Share price
$9.63 AUD
๐ฐ HIGH DIVIDEND
๐ธ FINANCIALS
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
๐ Performance (5Yr p.a)
8.45%
๐ Share price
$147.55 AUD
๐ธ FINANCIALS
๐ฆ๐บ AUSTRALIA
๐ HIGH PRICE GROWTH
โณ๏ธ DIVERSIFIED
Want more shares? Try these...
HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-12-12. The firm is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The firm offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Companyโs proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.
๐ Performance (5Yr p.a)
-14.67%
๐ Share price
$0.04 AUD
๐ฉบ HEALTH CARE